An improved in vitro model to characterize invasive growing cancer cells simultaneously by function and genetic aberrations

Toxicology in Vitro

Volumn 21, Issue 2, 2007, Pages 183-190

  Jung, V ^a   Wullich, B ^a   Kamradt, J ^a   Stockle M ^a   Unteregger, G ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

CGH; Primary cell culture; Prostatic carcinoma; Tumour invasion

Indexed keywords

ARTICLE; CANCER CELL; CANCER INVASION; CELL CULTURE; CELL GROWTH; CELL INVASION; CELL LINE; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; GENETIC ANALYSIS; GENOME; HUMAN; HUMAN CELL; IN VITRO STUDY; PROSTATE CANCER; PROSTATECTOMY; SPHEROID CELL;

CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; HUMANS; MALE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS;

EID: 33846841132     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2006.09.021     Document Type: Article

References (20)

1. Breitkreuz T., Romanakis K., Lutz S., Seitz G., Bonkhoff H., Unteregger G., Zwergel T., Zang K.D., and Wullich B. Genotypic characterization of prostatic carcinomas: a combined cytogenetic, flow cytometry, and in situ DNA hybridization study. Cancer Research 53 (1993) 4035-4040
2. Dawson L.A., Maitland N.J., Turner A.J., and Usmani B.A. Stromal-epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression. British Journal of Cancer 90 (2004) 1577-1582
3. Dong Z., Bonfil D., Chinni S., Deng X., Filho J.C.T., Bernardo M., Vaishampayan U., Che M., Sloane B., Sheng S., Fridman R., and Cher M. Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue. American Journal of Pathology 166 (2005) 1173-1186
4. Hall J.A., Maitland N.J., Stower M., and Lang S.H. Primary prostate stromal cells modulate the morphology and migration of primary prostate epithelial cells in type 1 collagen gels. Cancer Research 62 (2002) 58-62
5. Jung V., Romeike B.F., Henn W., Feiden W., Moringlane J.R., Zang K.D., and Urbschat S. Evidence of focal genetic microheterogeneity in glioblastoma multiforme by area-specific CGH on microdissected tumour cells. Journal of Neuropathology and Experimental Neurology 58 9 (1999) 993-999
6. Ketter R., Zwergel T., Romanakis K., Unteregger G., Ziegler M., Zang K.D., and Wullich B. Selection toward diploid cells in prostatic carcinoma derived cell cultures. Prostate 28 (1996) 364-371
7. Koenig J.J., van Dongen J.W., and Schroeder F.H. Preferential loss of abnormal prostate carcinoma cells by collagenase treatment. Cytometry 14 (1993) 805-810
8. Kwabi-Addo B., Ozen M., and Ittmann M. The role of fibroblast growth factors and their receptors in prostate cancer. Endocrine-Related Cancer 11 (2004) 709-724
9. Nakashiro K., Okamoto M., Hayashi Y., and Oyasu R. Hepatocyte growth factor secreted by prostate-derived stromal cells stimulate growth of androgen-independent human prostatic carcinoma cells. American Journal of Pathology 157 (2000) 795-803
10. Peehl D.M. Primary cell cultures as models of prostate cancer development. Endocrine-Related Cancer 12 (2005) 19-47
11. Peehl D.H. Are primary cultures realistic models of prostate cancer?. Journal of Cell Biochemistry 91 (2004) 185-195
12. Quinn D.I., Henshall M.S., and Sutherland R.L. Molecular markers of prostate cancer outcome. European Journal of Cancer 41 (2005) 858-887
13. Sabeh F., Holmbeck K., Birkedahl-Hansen H., Soloway P., Balbin M., Lopez-Otin C., Shapiro S., Inada M., Krane S., Allen E., Chung D., and Weiss S.J. Tumour cell traffic through the Extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. The Journal of Cell Biology 187 (2004) 769-781
14. Sattler H.P., Rohde V., Bonkhoff H., Zwergel T., and Wullich B. Comparative genomic hybridization reveals DNA copy number gains to frequently occur in human prostate cancer. Prostate 39 (1999) 79-86
15. Strohmeyer D.M., Berger A.P., Moore II D.H., Bartsch G., Klocker H., Carroll P.R., Loening S.A., and Jensen R.H. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis. Prostate 59 (2004) 43-58
16. Tuxhorn J., Ayala G.E., Smith M.J., Smith V.C., Dang T.D., and Rowley D.R. Reactive stroma in human prostate cancer: Induction of myofibroblast phenotype and Extracellular matrix remodeling. Clinical Cancer Research 8 (2002) 2912-2923
17. Walker J.A., Kilroy G.E., Xing J., Shewale J., Sinha S.K., and Batzer M.A. Human DNA quantification using Alu element-based polymerase chain reaction. Analytical Biochemistry 315 (2003) 122-128
18. 388allel is associated with protate cancer initiation and progression. Clinical Cancer Research 10 (2004) 6169-6178
19. Wullich B., Oehlenschläger B., Bonkhoff H., Ketter R., Zwergel T., Sattler H.P., and Rohde V. Focal intratumoural heterogeneity for telomerase activity in human prostate cancer. Journal of Urology 161 (1999) 1997-2001
20. Zwergel T., Kakirman H., Schorr H., Wullich B., and Unteregger G. A new serial transfer explant cell culture system for human prostatic cancer tissues preventing selection toward diploid cells. Cancer Genetics and Cytogenetics 101 (1998) 16-23